Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | ANNUAL REPORT | f20f2023_universe.htm iXBRL | 20-F | 1972102 |
2 | FOURTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND SECOND AMENDED AND RES | f20f2023ex1-1_universe.htm | EX-1.1 | 479481 |
3 | SPECIMEN CERTIFICATE FOR ORDINARY SHARES | f20f2023ex2-1_universe.htm | EX-2.1 | 3399 |
4 | DESCRIPTION OF SECURITIES | f20f2023ex2-3_universe.htm | EX-2.3 | 91708 |
5 | ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET | f20f2023ex4-6_universe.htm | EX-4.6 | 119516 |
6 | ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET | f20f2023ex4-7_universe.htm | EX-4.7 | 119604 |
7 | ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET | f20f2023ex4-8_universe.htm | EX-4.8 | 199868 |
8 | ENGLISH TRANSLATION OF THE LOAN CONTRACT ENTERED INTO BY AND BETWEEN JIANGXI UNI | f20f2023ex4-10_universe.htm | EX-4.10 | 120321 |
9 | ENGLISH TRANSLATION OF THE CORPORATE LOAN CONTRACT ENTERED INTO BY AND BETWEEN J | f20f2023ex4-11_universe.htm | EX-4.11 | 154921 |
10 | INSIDER TRADING POLICY | f20f2023ex11-2_universe.htm | EX-11.2 | 176003 |
11 | CERTIFICATION | f20f2023ex12-1_universe.htm | EX-12.1 | 9665 |
12 | CERTIFICATION | f20f2023ex12-2_universe.htm | EX-12.2 | 9605 |
13 | CERTIFICATION | f20f2023ex13-1_universe.htm | EX-13.1 | 3600 |
14 | CERTIFICATION | f20f2023ex13-2_universe.htm | EX-13.2 | 3599 |
15 | CONSENT OF ALLBRIGHT LAW OFFICES (FUZHOU) | f20f2023ex15-1_universe.htm | EX-15.1 | 7741 |
16 | CONSENT OF YCM CPA INC | f20f2023ex15-2_universe.htm | EX-15.2 | 3434 |
17 | COMPENSATION RECOVERY POLICY | f20f2023ex97-1_universe.htm | EX-97.1 | 41746 |
23 | GRAPHIC | image_001.jpg | GRAPHIC | 30353 |
24 | GRAPHIC | image_002.jpg | GRAPHIC | 20346 |
25 | GRAPHIC | image_003.jpg | GRAPHIC | 7621 |
26 | GRAPHIC | ex1-1_001.jpg | GRAPHIC | 1851 |
27 | GRAPHIC | ex4-6_001.jpg | GRAPHIC | 974 |
28 | GRAPHIC | ex4-6_002.jpg | GRAPHIC | 1639 |
29 | GRAPHIC | ex4-6_003.jpg | GRAPHIC | 1340 |
30 | GRAPHIC | ex4-6_004.jpg | GRAPHIC | 1617 |
31 | GRAPHIC | ex4-6_005.jpg | GRAPHIC | 2730 |
32 | GRAPHIC | ex4-6_006.jpg | GRAPHIC | 45055 |
33 | GRAPHIC | ex4-6_007.jpg | GRAPHIC | 20297 |
34 | GRAPHIC | ex4-7_001.jpg | GRAPHIC | 2643 |
35 | GRAPHIC | ex4-7_002.jpg | GRAPHIC | 1740 |
36 | GRAPHIC | ex4-7_003.jpg | GRAPHIC | 4840 |
37 | GRAPHIC | ex4-7_004.jpg | GRAPHIC | 1340 |
38 | GRAPHIC | ex4-7_005.jpg | GRAPHIC | 2623 |
39 | GRAPHIC | ex4-7_006.jpg | GRAPHIC | 7284 |
40 | GRAPHIC | ex4-7_007.jpg | GRAPHIC | 1617 |
41 | GRAPHIC | ex4-7_008.jpg | GRAPHIC | 2730 |
42 | GRAPHIC | ex4-8_001.jpg | GRAPHIC | 5943 |
43 | GRAPHIC | ex4-8_002.jpg | GRAPHIC | 51191 |
44 | GRAPHIC | ex4-8_003.jpg | GRAPHIC | 52444 |
45 | GRAPHIC | ex4-10_001.jpg | GRAPHIC | 5060 |
46 | GRAPHIC | ex4-10_002.jpg | GRAPHIC | 7094 |
47 | GRAPHIC | ex4-10_003.jpg | GRAPHIC | 3632 |
48 | GRAPHIC | ex4-11_001.jpg | GRAPHIC | 1775 |
49 | GRAPHIC | ex4-11_002.jpg | GRAPHIC | 6166 |
50 | GRAPHIC | ex4-11_003.jpg | GRAPHIC | 2087 |
51 | GRAPHIC | ex4-11_004.jpg | GRAPHIC | 7554 |
52 | GRAPHIC | ex15-1_001.jpg | GRAPHIC | 7251 |
53 | GRAPHIC | ex15-2_001.jpg | GRAPHIC | 8026 |
Complete submission text file | 0001213900-24-007745.txt | 10126332 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
18 | XBRL SCHEMA FILE | upc-20230930.xsd | EX-101.SCH | 91883 |
19 | XBRL CALCULATION FILE | upc-20230930_cal.xml | EX-101.CAL | 52819 |
20 | XBRL DEFINITION FILE | upc-20230930_def.xml | EX-101.DEF | 361722 |
21 | XBRL LABEL FILE | upc-20230930_lab.xml | EX-101.LAB | 619312 |
22 | XBRL PRESENTATION FILE | upc-20230930_pre.xml | EX-101.PRE | 374538 |
146 | EXTRACTED XBRL INSTANCE DOCUMENT | f20f2023_universe_htm.xml | XML | 752319 |
IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 20-F | Act: 34 | File No.: 001-40231 | Film No.: 24576715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)